Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma

20241 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov Identifier: NCT04928573. June 16, 2021, "retrospectively registered".

Published in: Oncology and Therapy

Volume 12, Issue 3, pp. 585-598

Field-Weighted Citation Impact: 0.43